IASO Bio Secures Singapore Approval for FUCASO CAR-T
SHANGHAI, NANJING, China, and PLEASANTON, Calif., June 18, 2026 IASO Bio has achieved a major international regulatory milestone with...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SHANGHAI, NANJING, China, and PLEASANTON, Calif., June 18, 2026 IASO Bio has achieved a major international regulatory milestone with...
INDIANAPOLIS, Ind., June 18, 2026 Elanco Animal Health Incorporated has announced plans to establish Elanco Ventures, a dedicated corporate...
SINGAPORE and SEOUL, South Korea, June 17, 2026 D&D Pharmatech and HistoIndex have announced encouraging new findings from an...
Stockholm — October 6, 2025. The Nobel Assembly at Karolinska Institutet has awarded the 2025 Nobel Prize in Physiology...
WEST HILLS, Calif., Oct. 8, 2025 — Thermo Fisher Scientific has introduced the Molecular Microscope® Diagnostic System for Lung...
